Rankings
▼
Calendar
VSTM Q3 2018 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
Gross Profit
$15M
99.5% margin
Operating Income
-$22M
-139.1% margin
Net Income
-$22M
-139.7% margin
EPS (Diluted)
$-3.53
QoQ Revenue Growth
+55.1%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$183M
Total Liabilities
$76M
Stockholders' Equity
$108M
Cash & Equivalents
$131M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$0
—
Gross Profit
$15M
$0
—
Operating Income
-$22M
-$23M
+6.8%
Net Income
-$22M
-$23M
+6.3%
Revenue Segments
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$72,000
56%
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$29,000
22%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$27,000
21%
Product Revenue And Allowances Returns
$1,000
1%
← FY 2018
All Quarters
Q4 2018 →